Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy ; volume:21 ; number:1 ; day:1 ; month:9 ; year:2022 ; pages:1-9 ; date:12.2022
Cardiovascular diabetology ; 21, Heft 1 (1.9.2022), 1-9, 12.2022
- Urheber
-
Pan, Yiheng
Davis, Pamela B.
Kaebler, David C.
Blankfield, Robert P.
Xu, Rong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-022-01610-9
- URN
-
urn:nbn:de:101:1-2022111909241109267088
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pan, Yiheng
- Davis, Pamela B.
- Kaebler, David C.
- Blankfield, Robert P.
- Xu, Rong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
Context-sensitive network analysis identifies food metabolites associated with Alzheimer’s disease: an exploratory study
Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing
Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
The horizontal-to-vertical spectral ratio and its applications
dRiskKB: a large-scale disease-disease risk relationship knowledge base constructed from biomedical text
Predict Alzheimer’s disease using hippocampus MRI data: a lightweight 3D deep convolutional network model with visual and global shape representations
Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
Context-sensitive network analysis identifies food metabolites associated with Alzheimer’s disease: an exploratory study
Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing
Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
The horizontal-to-vertical spectral ratio and its applications
dRiskKB: a large-scale disease-disease risk relationship knowledge base constructed from biomedical text
Predict Alzheimer’s disease using hippocampus MRI data: a lightweight 3D deep convolutional network model with visual and global shape representations
Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
Context-sensitive network analysis identifies food metabolites associated with Alzheimer’s disease: an exploratory study
Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing
Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
The horizontal-to-vertical spectral ratio and its applications
dRiskKB: a large-scale disease-disease risk relationship knowledge base constructed from biomedical text